Fig. 6From: Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parametersa–e The relationship between the clinically estimated radiobiological parameters and TCP. f 4D scatter plot demonstrating the relationship between the biological effective dose (\({\text{BED}}_{{{\text{exp}}}}\)), \(\alpha\) parameter, TCP, and the total liver lesion glycolysis \(\Delta {\text{TLG}}_{{{\text{liver}}}}\)Back to article page